Bettina Mahren

发表

Radioimmunotherapy with Anti-CD66 Antibody: Improving the Biodistribution Using a Physiologically Based Pharmacokinetic Model

Markus Luster, Thomas Kull, Gerhard Glatting, 2010, Journal of Nuclear Medicine.

Short Communication: (18)F-immuno-PET: Determination of anti-CD66 biodistribution in a patient with high-risk leukemia.

F. Mottaghy, G. Glatting, A. Buck, 2008, Cancer biotherapy & radiopharmaceuticals.

Targeting bcl-2 by triplex-forming oligonucleotide--a promising carrier for gene-radiotherapy.

H. Schirrmeister, A. Buck, S. Reske, 2003, Cancer biotherapy & radiopharmaceuticals.

Population-Based Modeling Improves Treatment Planning Before (90)Y-Labeled Anti-CD66 Antibody Radioimmunotherapy.

G. Glatting, A. Beer, P. Kletting, 2015, Cancer biotherapy & radiopharmaceuticals.